Global Radiopharmaceutical Market Insights and Forecast to 2027

Global Radiopharmaceutical Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Radiopharmaceutical Product Introduction
1.2 Market by Type
1.2.1 Global Radiopharmaceutical Market Size Growth Rate by Type
1.4.2 Actinium-225
1.4.3 Lutetium-177
1.2.4 Radium-223
1.2.5 Holmium-166
1.2.6 Other
1.3 Market by Application
1.3.1 Global Radiopharmaceutical Market Size Growth Rate by Application
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceutical Sales Estimates and Forecasts 2016-2027
2.2 Global Radiopharmaceutical Revenue Estimates and Forecasts 2016-2027
2.3 Global Radiopharmaceutical Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Radiopharmaceutical Regions by Sales
2.4.1 Global Top Radiopharmaceutical Regions by Sales (2016-2021)
2.4.2 Global Top Radiopharmaceutical Regions by Sales (2022-2027)
2.5 Global Top Radiopharmaceutical Regions by Revenue
2.5.1 Global Top Radiopharmaceutical Regions by Revenue (2016-2021)
2.5.2 Global Top Radiopharmaceutical Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Radiopharmaceutical Sales by Manufacturers
3.1.1 Global Top Radiopharmaceutical Manufacturers by Sales (2016-2021)
3.1.2 Global Top Radiopharmaceutical Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Radiopharmaceutical Sales in 2020
3.2 Global Radiopharmaceutical Revenue by Manufacturers
3.2.1 Global Top Radiopharmaceutical Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Radiopharmaceutical Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Radiopharmaceutical Revenue in 2020
3.3 Global Radiopharmaceutical Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Radiopharmaceutical Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Radiopharmaceutical Sales by Type
4.1.1 Global Radiopharmaceutical Historical Sales by Type (2016-2021)
4.1.2 Global Radiopharmaceutical Forecasted Sales by Type (2022-2027)
4.1.3 Global Radiopharmaceutical Sales Market Share by Type (2016-2027)
4.2 Global Radiopharmaceutical Revenue by Type
4.2.1 Global Radiopharmaceutical Historical Revenue by Type (2016-2021)
4.2.2 Global Radiopharmaceutical Forecasted Revenue by Type (2022-2027)
4.2.3 Global Radiopharmaceutical Revenue Market Share by Type (2016-2027)
4.3 Global Radiopharmaceutical Price by Type
4.3.1 Global Radiopharmaceutical Price by Type (2016-2021)
4.3.2 Global Radiopharmaceutical Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Radiopharmaceutical Sales by Application
5.1.1 Global Radiopharmaceutical Historical Sales by Application (2016-2021)
5.1.2 Global Radiopharmaceutical Forecasted Sales by Application (2022-2027)
5.1.3 Global Radiopharmaceutical Sales Market Share by Application (2016-2027)
5.2 Global Radiopharmaceutical Revenue by Application
5.2.1 Global Radiopharmaceutical Historical Revenue by Application (2016-2021)
5.2.2 Global Radiopharmaceutical Forecasted Revenue by Application (2022-2027)
5.2.3 Global Radiopharmaceutical Revenue Market Share by Application (2016-2027)
5.3 Global Radiopharmaceutical Price by Application
5.3.1 Global Radiopharmaceutical Price by Application (2016-2021)
5.3.2 Global Radiopharmaceutical Price Forecast by Application (2022-2027)
6 North America
6.1 North America Radiopharmaceutical Market Size by Type
6.1.1 North America Radiopharmaceutical Sales by Type (2016-2027)
6.1.2 North America Radiopharmaceutical Revenue by Type (2016-2027)
6.2 North America Radiopharmaceutical Market Size by Application
6.2.1 North America Radiopharmaceutical Sales by Application (2016-2027)
6.2.2 North America Radiopharmaceutical Revenue by Application (2016-2027)
6.3 North America Radiopharmaceutical Market Size by Country
6.3.1 North America Radiopharmaceutical Sales by Country (2016-2027)
6.3.2 North America Radiopharmaceutical Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Radiopharmaceutical Market Size by Type
7.1.1 Europe Radiopharmaceutical Sales by Type (2017-2027)
7.1.2 Europe Radiopharmaceutical Revenue by Type (2017-2027)
7.2 Europe Radiopharmaceutical Market Size by Application
7.2.1 Europe Radiopharmaceutical Sales by Application (2017-2027)
7.2.2 Europe Radiopharmaceutical Revenue by Application (2017-2027)
7.3 Europe Radiopharmaceutical Market Size by Country
7.3.1 Europe Radiopharmaceutical Sales by Country (2017-2027)
7.3.2 Europe Radiopharmaceutical Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Radiopharmaceutical Market Size by Type
8.1.1 Asia Pacific Radiopharmaceutical Sales by Type (2018-2027)
8.1.2 Asia Pacific Radiopharmaceutical Revenue by Type (2018-2027)
8.2 Asia Pacific Radiopharmaceutical Market Size by Application
8.2.1 Asia Pacific Radiopharmaceutical Sales by Application (2018-2027)
8.2.2 Asia Pacific Radiopharmaceutical Revenue by Application (2018-2027)
8.3 Asia Pacific Radiopharmaceutical Market Size by Region
8.3.1 Asia Pacific Radiopharmaceutical Sales by Region (2018-2027)
8.3.2 Asia Pacific Radiopharmaceutical Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Radiopharmaceutical Market Size by Type
9.1.1 Latin America Radiopharmaceutical Sales by Type (2019-2027)
9.1.2 Latin America Radiopharmaceutical Revenue by Type (2019-2027)
9.2 Latin America Radiopharmaceutical Market Size by Application
9.2.1 Latin America Radiopharmaceutical Sales by Application (2019-2027)
9.2.2 Latin America Radiopharmaceutical Revenue by Application (2019-2027)
9.3 Latin America Radiopharmaceutical Market Size by Country
9.3.1 Latin America Radiopharmaceutical Sales by Country (2019-2027)
9.3.2 Latin America Radiopharmaceutical Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Radiopharmaceutical Market Size by Type
6.1.1 Middle East and Africa Radiopharmaceutical Sales by Type (2016-2027)
6.1.2 Middle East and Africa Radiopharmaceutical Revenue by Type (2016-2027)
6.2 Middle East and Africa Radiopharmaceutical Market Size by Application
6.2.1 Middle East and Africa Radiopharmaceutical Sales by Application (2016-2027)
6.2.2 Middle East and Africa Radiopharmaceutical Revenue by Application (2016-2027)
6.3 Middle East and Africa Radiopharmaceutical Market Size by Country
6.3.1 Middle East and Africa Radiopharmaceutical Sales by Country (2016-2027)
6.3.2 Middle East and Africa Radiopharmaceutical Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Bracco Imaging
11.1.1 Bracco Imaging Corporation Information
11.1.2 Bracco Imaging Overview
11.1.3 Bracco Imaging Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Bracco Imaging Radiopharmaceutical Product Description
11.1.5 Bracco Imaging Related Developments
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Overview
11.2.3 Bayer Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Bayer Radiopharmaceutical Product Description
11.2.5 Bayer Related Developments
11.3 Mallinckrodt
11.3.1 Mallinckrodt Corporation Information
11.3.2 Mallinckrodt Overview
11.3.3 Mallinckrodt Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Mallinckrodt Radiopharmaceutical Product Description
11.3.5 Mallinckrodt Related Developments
11.4 Nordion
11.4.1 Nordion Corporation Information
11.4.2 Nordion Overview
11.4.3 Nordion Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Nordion Radiopharmaceutical Product Description
11.4.5 Nordion Related Developments
11.5 Triad Isotopes
11.5.1 Triad Isotopes Corporation Information
11.5.2 Triad Isotopes Overview
11.5.3 Triad Isotopes Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Triad Isotopes Radiopharmaceutical Product Description
11.5.5 Triad Isotopes Related Developments
11.6 Lantheus
11.6.1 Lantheus Corporation Information
11.6.2 Lantheus Overview
11.6.3 Lantheus Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Lantheus Radiopharmaceutical Product Description
11.6.5 Lantheus Related Developments
11.7 IBA Group
11.7.1 IBA Group Corporation Information
11.7.2 IBA Group Overview
11.7.3 IBA Group Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 IBA Group Radiopharmaceutical Product Description
11.7.5 IBA Group Related Developments
11.8 GE Healthcare
11.8.1 GE Healthcare Corporation Information
11.8.2 GE Healthcare Overview
11.8.3 GE Healthcare Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 GE Healthcare Radiopharmaceutical Product Description
11.8.5 GE Healthcare Related Developments
11.9 China Isotope & Radiation
11.9.1 China Isotope & Radiation Corporation Information
11.9.2 China Isotope & Radiation Overview
11.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 China Isotope & Radiation Radiopharmaceutical Product Description
11.9.5 China Isotope & Radiation Related Developments
11.10 Jubilant Pharma
11.10.1 Jubilant Pharma Corporation Information
11.10.2 Jubilant Pharma Overview
11.10.3 Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Jubilant Pharma Radiopharmaceutical Product Description
11.10.5 Jubilant Pharma Related Developments
11.1 Bracco Imaging
11.1.1 Bracco Imaging Corporation Information
11.1.2 Bracco Imaging Overview
11.1.3 Bracco Imaging Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Bracco Imaging Radiopharmaceutical Product Description
11.1.5 Bracco Imaging Related Developments
11.12 Advanced Accelerator Applications
11.12.1 Advanced Accelerator Applications Corporation Information
11.12.2 Advanced Accelerator Applications Overview
11.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Advanced Accelerator Applications Product Description
11.12.5 Advanced Accelerator Applications Related Developments
11.13 SIEMENS
11.13.1 SIEMENS Corporation Information
11.13.2 SIEMENS Overview
11.13.3 SIEMENS Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 SIEMENS Product Description
11.13.5 SIEMENS Related Developments
11.14 Dongcheng
11.14.1 Dongcheng Corporation Information
11.14.2 Dongcheng Overview
11.14.3 Dongcheng Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Dongcheng Product Description
11.14.5 Dongcheng Related Developments
11.15 Navidea
11.15.1 Navidea Corporation Information
11.15.2 Navidea Overview
11.15.3 Navidea Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 Navidea Product Description
11.15.5 Navidea Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Radiopharmaceutical Value Chain Analysis
12.2 Radiopharmaceutical Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Radiopharmaceutical Production Mode & Process
12.4 Radiopharmaceutical Sales and Marketing
12.4.1 Radiopharmaceutical Sales Channels
12.4.2 Radiopharmaceutical Distributors
12.5 Radiopharmaceutical Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Radiopharmaceutical Industry Trends
13.2 Radiopharmaceutical Market Drivers
13.3 Radiopharmaceutical Market Challenges
13.4 Radiopharmaceutical Market Restraints
14 Key Findings in The Global Radiopharmaceutical Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Radiopharmaceutical Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Actinium-225
Table 3. Major Manufacturers of Lutetium-177
Table 4. Major Manufacturers of Radium-223
Table 5. Major Manufacturers of Holmium-166
Table 6. Major Manufacturers of Other
Table 7. Global Radiopharmaceutical Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 8. Global Radiopharmaceutical Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 9. Global Radiopharmaceutical Sales by Region (2016-2021) & (M Doses)
Table 10. Global Radiopharmaceutical Sales Market Share by Region (2016-2021)
Table 11. Global Radiopharmaceutical Sales by Region (2016-2021) & (M Doses)
Table 12. Global Radiopharmaceutical Sales Market Share by Region (2022-2027)
Table 13. Global Radiopharmaceutical Revenue by Region (2016-2021) & (US$ Million)
Table 14. Global Radiopharmaceutical Revenue Market Share by Region (2016-2021)
Table 15. Global Radiopharmaceutical Revenue by Region (2022-2027) & (US$ Million)
Table 16. Global Radiopharmaceutical Revenue Market Share by Region (2022-2027)
Table 17. Global Radiopharmaceutical Sales by Manufacturers (2016-2021) & (M Doses)
Table 18. Global Radiopharmaceutical Sales Share by Manufacturers (2016-2021)
Table 19. Global Radiopharmaceutical Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 20. Global Radiopharmaceutical Revenue Share by Manufacturers (2016-2021)
Table 21. Radiopharmaceutical Price by Manufacturers 2016-2021 (USD/Dose)
Table 22. Global Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2020)
Table 24. Radiopharmaceutical Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Radiopharmaceutical Product Offered
Table 26. Date of Manufacturers Enter into Radiopharmaceutical Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Radiopharmaceutical Sales by Type (2016-2021) & (M Doses)
Table 29. Global Radiopharmaceutical Sales by Type (2022-2027) & (M Doses)
Table 30. Global Radiopharmaceutical Sales Share by Type (2016-2021)
Table 31. Global Radiopharmaceutical Sales Share by Type (2022-2027)
Table 32. Global Radiopharmaceutical Revenue by Type (2016-2021) & (US$ Million)
Table 33. Global Radiopharmaceutical Revenue by Type (2022-2027) & (US$ Million)
Table 34. Global Radiopharmaceutical Revenue Share by Type (2016-2021)
Table 35. Global Radiopharmaceutical Revenue Share by Type (2022-2027)
Table 36. Radiopharmaceutical Price by Type (2016-2021) & (USD/Dose)
Table 37. Global Radiopharmaceutical Price Forecast by Type (2022-2027) & (USD/Dose)
Table 38. Global Radiopharmaceutical Sales by Application (2016-2021) & (M Doses)
Table 39. Global Radiopharmaceutical Sales by Application (2022-2027) & (M Doses)
Table 40. Global Radiopharmaceutical Sales Share by Application (2016-2021)
Table 41. Global Radiopharmaceutical Sales Share by Application (2022-2027)
Table 42. Global Radiopharmaceutical Revenue by Application (2016-2021) & (US$ Million)
Table 43. Global Radiopharmaceutical Revenue by Application (2022-2027) & (US$ Million)
Table 44. Global Radiopharmaceutical Revenue Share by Application (2016-2021)
Table 45. Global Radiopharmaceutical Revenue Share by Application (2022-2027)
Table 46. Radiopharmaceutical Price by Application (2016-2021) & (USD/Dose)
Table 47. Global Radiopharmaceutical Price Forecast by Application (2022-2027) & (USD/Dose)
Table 48. North America Radiopharmaceutical Sales by Type (2016-2021) & (M Doses)
Table 49. North America Radiopharmaceutical Sales by Type (2022-2027) & (M Doses)
Table 50. North America Radiopharmaceutical Revenue by Type (2016-2021) & (US$ Million)
Table 51. North America Radiopharmaceutical Revenue by Type (2022-2027) & (US$ Million)
Table 52. North America Radiopharmaceutical Sales by Application (2016-2021) & (M Doses)
Table 53. North America Radiopharmaceutical Sales by Application (2022-2027) & (M Doses)
Table 54. North America Radiopharmaceutical Revenue by Application (2016-2021) & (US$ Million)
Table 55. North America Radiopharmaceutical Revenue by Application (2022-2027) & (US$ Million)
Table 56. North America Radiopharmaceutical Sales by Country (2016-2021) & (M Doses)
Table 57. North America Radiopharmaceutical Sales by Country (2022-2027) & (M Doses)
Table 58. North America Radiopharmaceutical Revenue by Country (2016-2021) & (US$ Million)
Table 59. North America Radiopharmaceutical Revenue by Country (2022-2027) & (US$ Million)
Table 60. Europe Radiopharmaceutical Sales by Type (2016-2021) & (M Doses)
Table 61. Europe Radiopharmaceutical Sales by Type (2022-2027) & (M Doses)
Table 62. Europe Radiopharmaceutical Revenue by Type (2016-2021) & (US$ Million)
Table 63. Europe Radiopharmaceutical Revenue by Type (2022-2027) & (US$ Million)
Table 64. Europe Radiopharmaceutical Sales by Application (2016-2021) & (M Doses)
Table 65. Europe Radiopharmaceutical Sales by Application (2022-2027) & (M Doses)
Table 66. Europe Radiopharmaceutical Revenue by Application (2016-2021) & (US$ Million)
Table 67. Europe Radiopharmaceutical Revenue by Application (2022-2027) & (US$ Million)
Table 68. Europe Radiopharmaceutical Sales by Country (2016-2021) & (M Doses)
Table 69. Europe Radiopharmaceutical Sales by Country (2022-2027) & (M Doses)
Table 70. Europe Radiopharmaceutical Revenue by Country (2016-2021) & (US$ Million)
Table 71. Europe Radiopharmaceutical Revenue by Country (2022-2027) & (US$ Million)
Table 72. Asia Pacific Radiopharmaceutical Sales by Type (2016-2021) & (M Doses)
Table 73. Asia Pacific Radiopharmaceutical Sales by Type (2022-2027) & (M Doses)
Table 74. Asia Pacific Radiopharmaceutical Revenue by Type (2016-2021) & (US$ Million)
Table 75. Asia Pacific Radiopharmaceutical Revenue by Type (2022-2027) & (US$ Million)
Table 76. Asia Pacific Radiopharmaceutical Sales by Application (2016-2021) & (M Doses)
Table 77. Asia Pacific Radiopharmaceutical Sales by Application (2022-2027) & (M Doses)
Table 78. Asia Pacific Radiopharmaceutical Revenue by Application (2016-2021) & (US$ Million)
Table 79. Asia Pacific Radiopharmaceutical Revenue by Application (2022-2027) & (US$ Million)
Table 80. Asia Pacific Radiopharmaceutical Sales by Region (2016-2021) & (M Doses)
Table 81. Asia Pacific Radiopharmaceutical Sales by Region (2022-2027) & (M Doses)
Table 82. Asia Pacific Radiopharmaceutical Revenue by Region (2016-2021) & (US$ Million)
Table 83. Asia Pacific Radiopharmaceutical Revenue by Region (2022-2027) & (US$ Million)
Table 84. Latin America Radiopharmaceutical Sales by Type (2016-2021) & (M Doses)
Table 85. Latin America Radiopharmaceutical Sales by Type (2022-2027) & (M Doses)
Table 86. Latin America Radiopharmaceutical Revenue by Type (2016-2021) & (US$ Million)
Table 87. Latin America Radiopharmaceutical Revenue by Type (2022-2027) & (US$ Million)
Table 88. Latin America Radiopharmaceutical Sales by Application (2016-2021) & (M Doses)
Table 89. Latin America Radiopharmaceutical Sales by Application (2022-2027) & (M Doses)
Table 90. Latin America Radiopharmaceutical Revenue by Application (2016-2021) & (US$ Million)
Table 91. Latin America Radiopharmaceutical Revenue by Application (2022-2027) & (US$ Million)
Table 92. Latin America Radiopharmaceutical Sales by Country (2016-2021) & (M Doses)
Table 93. Latin America Radiopharmaceutical Sales by Country (2022-2027) & (M Doses)
Table 94. Latin America Radiopharmaceutical Revenue by Country (2016-2021) & (US$ Million)
Table 95. Latin America Radiopharmaceutical Revenue by Country (2022-2027) & (US$ Million)
Table 96. Middle East and Africa Radiopharmaceutical Sales by Type (2016-2021) & (M Doses)
Table 97. Middle East and Africa Radiopharmaceutical Sales by Type (2022-2027) & (M Doses)
Table 98. Middle East and Africa Radiopharmaceutical Revenue by Type (2016-2021) & (US$ Million)
Table 99. Middle East and Africa Radiopharmaceutical Revenue by Type (2022-2027) & (US$ Million)
Table 100. Middle East and Africa Radiopharmaceutical Sales by Application (2016-2021) & (M Doses)
Table 101. Middle East and Africa Radiopharmaceutical Sales by Application (2022-2027) & (M Doses)
Table 102. Middle East and Africa Radiopharmaceutical Revenue by Application (2016-2021) & (US$ Million)
Table 103. Middle East and Africa Radiopharmaceutical Revenue by Application (2022-2027) & (US$ Million)
Table 104. Middle East and Africa Radiopharmaceutical Sales by Country (2016-2021) & (M Doses)
Table 105. Middle East and Africa Radiopharmaceutical Sales by Country (2022-2027) & (M Doses)
Table 106. Middle East and Africa Radiopharmaceutical Revenue by Country (2016-2021) & (US$ Million)
Table 107. Middle East and Africa Radiopharmaceutical Revenue by Country (2022-2027) & (US$ Million)
Table 108. Bracco Imaging Corporation Information
Table 109. Bracco Imaging Description and Major Businesses
Table 110. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 111. Bracco Imaging Radiopharmaceutical Product
Table 112. Bracco Imaging Recent Developments
Table 113. Bayer Corporation Information
Table 114. Bayer Description and Major Businesses
Table 115. Bayer Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 116. Bayer Radiopharmaceutical Product
Table 117. Bayer Recent Developments
Table 118. Mallinckrodt Corporation Information
Table 119. Mallinckrodt Description and Major Businesses
Table 120. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 121. Mallinckrodt Radiopharmaceutical Product
Table 122. Mallinckrodt Recent Developments
Table 123. Nordion Corporation Information
Table 124. Nordion Description and Major Businesses
Table 125. Nordion Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 126. Nordion Radiopharmaceutical Product
Table 127. Nordion Recent Developments
Table 128. Triad Isotopes Corporation Information
Table 129. Triad Isotopes Description and Major Businesses
Table 130. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 131. Triad Isotopes Radiopharmaceutical Product
Table 132. Triad Isotopes Recent Developments
Table 133. Lantheus Corporation Information
Table 134. Lantheus Description and Major Businesses
Table 135. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 136. Lantheus Radiopharmaceutical Product
Table 137. Lantheus Recent Developments
Table 138. IBA Group Corporation Information
Table 139. IBA Group Description and Major Businesses
Table 140. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 141. IBA Group Radiopharmaceutical Product
Table 142. IBA Group Recent Developments
Table 143. GE Healthcare Corporation Information
Table 144. GE Healthcare Description and Major Businesses
Table 145. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 146. GE Healthcare Radiopharmaceutical Product
Table 147. GE Healthcare Recent Developments
Table 148. China Isotope & Radiation Corporation Information
Table 149. China Isotope & Radiation Description and Major Businesses
Table 150. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 151. China Isotope & Radiation Radiopharmaceutical Product
Table 152. China Isotope & Radiation Recent Developments
Table 153. Jubilant Pharma Corporation Information
Table 154. Jubilant Pharma Description and Major Businesses
Table 155. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 156. Jubilant Pharma Radiopharmaceutical Product
Table 157. Jubilant Pharma Recent Developments
Table 158. Eli Lilly Corporation Information
Table 159. Eli Lilly Description and Major Businesses
Table 160. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 161. Eli Lilly Radiopharmaceutical Product
Table 162. Eli Lilly Recent Developments
Table 163. Advanced Accelerator Applications Corporation Information
Table 164. Advanced Accelerator Applications Description and Major Businesses
Table 165. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 166. Advanced Accelerator Applications Radiopharmaceutical Product
Table 167. Advanced Accelerator Applications Recent Developments
Table 168. SIEMENS Corporation Information
Table 169. SIEMENS Description and Major Businesses
Table 170. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 171. SIEMENS Radiopharmaceutical Product
Table 172. SIEMENS Recent Developments
Table 173. Dongcheng Corporation Information
Table 174. Dongcheng Description and Major Businesses
Table 175. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 176. Dongcheng Radiopharmaceutical Product
Table 177. Dongcheng Recent Developments
Table 178. Navidea Corporation Information
Table 179. Navidea Description and Major Businesses
Table 180. Navidea Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 181. Navidea Radiopharmaceutical Product
Table 182. Navidea Recent Developments
Table 183. Key Raw Materials Lists
Table 184. Raw Materials Key Suppliers Lists
Table 185. Radiopharmaceutical Distributors List
Table 186. Radiopharmaceutical Customers List
Table 187. Radiopharmaceutical Market Trends
Table 188. Radiopharmaceutical Market Drivers
Table 189. Radiopharmaceutical Market Challenges
Table 190. Radiopharmaceutical Market Restraints
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceutical Product Picture
Figure 2. Global Radiopharmaceutical Market Share by Type in 2020 & 2027
Figure 3. Actinium-225 Product Picture
Figure 4. Lutetium-177 Product Picture
Figure 5. Radium-223 Product Picture
Figure 6. Holmium-166 Product Picture
Figure 7. Other Product Picture
Figure 8. Global Radiopharmaceutical Sales Market Share by Application in 2020 & 2027
Figure 9. Oncology
Figure 10. Cardiology
Figure 11. Other
Figure 12. Radiopharmaceutical Report Years Considered
Figure 13. Global Radiopharmaceutical Sales 2016-2027 (M Doses)
Figure 14. Global Radiopharmaceutical Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Radiopharmaceutical Revenue 2016-2027 (US$ Million)
Figure 16. Global Radiopharmaceutical Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 17. Global Radiopharmaceutical Sales Market Share by Region (2016-2021)
Figure 18. Global Radiopharmaceutical Sales Market Share by Region (2022-2027)
Figure 19. North America Radiopharmaceutical Sales YoY (2016-2027) & (M Doses)
Figure 20. North America Radiopharmaceutical Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Europe Radiopharmaceutical Sales YoY (2016-2027) & (M Doses)
Figure 22. Europe Radiopharmaceutical Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Asia-Pacific Radiopharmaceutical Sales YoY (2016-2027) & (M Doses)
Figure 24. Asia-Pacific Radiopharmaceutical Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Latin America Radiopharmaceutical Sales YoY (2016-2027) & (M Doses)
Figure 26. Latin America Radiopharmaceutical Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Middle East & Africa Radiopharmaceutical Sales YoY (2016-2027) & (M Doses)
Figure 28. Middle East & Africa Radiopharmaceutical Revenue YoY (2016-2027) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Radiopharmaceutical Sales in 2020
Figure 30. The Top 10 and Top 5 Players Market Share by Radiopharmaceutical Revenue in 2020
Figure 31. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 32. Global Radiopharmaceutical Sales Market Share by Type (2016-2027)
Figure 33. Global Radiopharmaceutical Revenue Market Share by Type (2016-2027)
Figure 34. Global Radiopharmaceutical Sales Market Share by Application (2016-2027)
Figure 35. Global Radiopharmaceutical Revenue Market Share by Application (2016-2027)
Figure 36. North America Radiopharmaceutical Sales Market Share by Type (2016-2027)
Figure 37. North America Radiopharmaceutical Revenue Market Share by Type (2016-2027)
Figure 38. North America Radiopharmaceutical Sales Market Share by Application (2016-2027)
Figure 39. North America Radiopharmaceutical Revenue Market Share by Application (2016-2027)
Figure 40. North America Radiopharmaceutical Sales Share by Country (2016-2027)
Figure 41. North America Radiopharmaceutical Revenue Share by Country (2016-2027)
Figure 42. U.S. Radiopharmaceutical Revenue (2016-2027) & (US$ Million)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Radiopharmaceutical Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125

According to our LPI (LP Information) latest study, the global Radiopharmaceutical market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceutical is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Radiopharmaceutical market. Radiopharmaceutical are expected to show stable growth in the future market. However, produ......

Global Radiopharmaceuticals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 138

According to our LPI (LP Information) latest study, the global Radiopharmaceuticals market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceuticals is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Radiopharmaceuticals market. Radiopharmaceuticals are expected to show stable growth in the future market. However, p......

Global Radiopharmaceutical Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 137

According to our (Global Info Research) latest study, the global Radiopharmaceutical market size was valued at USD 6956.7 million in 2023 and is forecast to a readjusted size of USD 11660 million by 2030 with a CAGR of 7.7% during review period. Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule con......

Global Radiation Dose Management Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 88

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Radiation Dose Management market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Landauer - Sectra AB - Afga-Gevaert - INFINITT Healthcare - Bayer Healthcare - PACSHealth - Koninklijke Philips - GE Healthcar......

Global Radiation Dose Management Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 111

Market Overview of Global Radiation Dose Management market: According to our latest research, the global Radiation Dose Management market looks promising in the next 5 years. As of 2022, the global Radiation Dose Management market was estimated at USD 484.67 million, and it's anticipated to reach USD 1069.95 million in 2028, with a CAGR of 14.11% during the forecast years. The radiation dose management channel includes information of radiation dose recording software, real-ti......

Global Radiation Dose Management Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124

Report Overview: The Global Radiation Dose Management Market Size was estimated at USD 862.70 million in 2022 and is projected to reach USD 3695.44 million by 2029, exhibiting a CAGR of 23.10% during the forecast period. This report provides a deep insight into the global Radiation Dose Management market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche marke......

Global Radiopharmaceutical Professional Survey Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 3280 Onwards        Pages: 133

Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......

Global Radiopharmaceutical Market Research Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 166

Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......

Global Radiopharmaceutical Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Nov-2023        Price: US 3380 Onwards        Pages: 116

Market Overview of Global Radiopharmaceutical market: According to our latest research, the global Radiopharmaceutical market looks promising in the next 5 years. As of 2022, the global Radiopharmaceutical market was estimated at USD 7319.21 million, and it's anticipated to reach USD 13640.5 million in 2028, with a CAGR of 10.93% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global R......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs